Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1 224
1 141 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1 143.12 |
+0%
|
$1.1T |
|
|
|
Johnson & Johnson
JNJ
|
$252.93 |
-1.2%
|
$609.5B |
|
|
|
Merck & Co Inc
MRK
|
$139.54 |
-3.3%
|
$344.6B |
|
|
|
Novartis AG
NOVN
|
CHf117.52 |
+0.9%
|
$269.6B |
|
|
|
AstraZeneca PLC
AZN
|
12 060 |
+2.5%
|
$247.7B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$44.03 |
+3%
|
$226B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr248.25 |
+0.6%
|
$165.2B |
|
|
|
Pfizer Inc
PFE
|
$27.41 |
-1.4%
|
$156.2B |
|
|
|
Bristol-Myers Squibb Co
BMY
|
$58.81 |
-3.8%
|
$120.1B |
1 136 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account